VYNE Therapeutics Inc. (VYNE) Q2 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings and welcome to the Vine Therapeutics second quarter 2021 earnings call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question and answer session. At that time, if you have a question, please press the 1 followed by the 4 on your telephone. If any time during the conference you need to reach an operator, please press star 0. As a reminder, this conference is being recorded Thursday, August 12, 2021. I would now like to turn the conference over to Chase Oswald from LifeSci Advisors. Please go ahead. Good morning, everyone, and thank you for joining us. Before we begin formal remarks, let me remind you that some of the information in the press release issued this morning and on this conference call contain forward-looking statements that involve risks, uncertainties, and assumptions that are difficult to predict, including statements, forecasts, and observations on financial and operating performance, impacts of the COVID-19 pandemic on Vine, and observations regarding ongoing operating expenses and net revenues. These statements will include observations associated with the commercialization of Amzeek and Zilxie in the United States. They will also include plans and expectations regarding strategic transactions and the success, timing, and cost of clinical trials. Words that express and reflect optimism, satisfaction with current progress, prospects, or projections, as well as words such as believe, intend, expect, plan, anticipate, and similar variations identify forward-looking statements. but their absence does not mean that statement is not forward-looking. Such forward-looking statements are not a guarantee of performance, and a company's actual results could differ materially from those contained...